Business Description
Cordyceps Sunshine Biotech Holdings Co Ltd
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | -0.02 | |||||
Debt-to-Equity | -8.58 | |||||
Debt-to-EBITDA | 2.31 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -0.15 | |||||
Beneish M-Score | 11.58 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.11 | |||||
Quick Ratio | 0.05 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 2013.39 | |||||
Days Sales Outstanding | 173.26 | |||||
Days Payable | 24572.74 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 90.19 | |||||
Operating Margin % | 37.34 | |||||
Net Margin % | 307.91 | |||||
FCF Margin % | 37.34 | |||||
ROE % | Neg. Equity | |||||
ROA % | 39.85 | |||||
ROIC % | 6.62 | |||||
ROC (Joel Greenblatt) % | 7.01 | |||||
ROCE % | 86.34 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 4.44 | |||||
PE Ratio without NRI | 40 | |||||
PS Ratio | 13.33 | |||||
Price-to-Free-Cash-Flow | 40 | |||||
Price-to-Operating-Cash-Flow | 13.33 | |||||
EV-to-EBIT | 43.29 | |||||
EV-to-EBITDA | 17.43 | |||||
EV-to-Revenue | 16.16 | |||||
EV-to-FCF | 43.29 | |||||
Earnings Yield (Greenblatt) % | 2.31 | |||||
FCF Yield % | 2.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RAJAF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cordyceps Sunshine Biotech Holdings Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.316 | ||
EPS (TTM) ($) | 0.009 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 0.04 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 0.04 - 0.04 | ||
Shares Outstanding (Mil) | 111.12 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cordyceps Sunshine Biotech Holdings Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cordyceps Sunshine Biotech Holdings Co Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Cordyceps Sunshine Biotech Holdings Co Ltd Frequently Asked Questions
What is Cordyceps Sunshine Biotech Holdings Co Ltd(RAJAF)'s stock price today?
When is next earnings date of Cordyceps Sunshine Biotech Holdings Co Ltd(RAJAF)?
Does Cordyceps Sunshine Biotech Holdings Co Ltd(RAJAF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |